3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
21 23 0 0 0 0 0 0 0999 V2000
4.4519 -0.7708 0.0016 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.2155 1.0931 -0.0013 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1723 -1.1291 -0.0004 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7405 1.1666 0.0004 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.5297 0.7015 -0.0005 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4762 -0.6896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5563 -0.0354 -0.0012 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0304 -0.0181 -0.0018 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7240 1.4229 -0.0002 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6760 -1.4210 0.0010 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9086 0.6789 0.0006 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8874 -0.7178 0.0012 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7846 -1.1728 -0.0018 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0260 0.8915 0.0024 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1196 2.0475 -0.0018 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.7380 2.5068 -0.0006 H 1 0 0 0 0 0 0 0 0 0 0 0
-2.6700 -2.5063 0.0015 H 1 0 0 0 0 0 0 0 0 0 0 0
-4.8636 1.1985 0.0008 H 1 0 0 0 0 0 0 0 0 0 0 0
-4.8246 -1.2684 0.0019 H 1 0 0 0 0 0 0 0 0 0 0 0
2.4592 -2.2040 -0.0028 H 0 0 0 0 0 0 0 0 0 0 0 0
4.7799 1.6667 0.0044 H 0 0 0 0 0 0 0 0 0 0 0 0
1 13 1 0 0 0 0
1 14 1 0 0 0 0
2 5 1 0 0 0 0
2 7 1 0 0 0 0
2 15 1 0 0 0 0
3 6 1 0 0 0 0
3 7 2 0 0 0 0
4 8 1 0 0 0 0
4 14 2 0 0 0 0
5 6 1 0 0 0 0
5 9 2 0 0 0 0
6 10 2 0 0 0 0
7 8 1 0 0 0 0
8 13 2 0 0 0 0
9 11 1 0 0 0 0
9 16 1 0 0 0 0
10 12 1 0 0 0 0
10 17 1 0 0 0 0
11 12 2 0 0 0 0
11 18 1 0 0 0 0
12 19 1 0 0 0 0
13 20 1 0 0 0 0
14 21 1 0 0 0 0
M ISO 4 16 2 17 2 18 2 19 2
4. 国际命名与标识
4.1 IUPAC Name
4-(4,5,6,7-tetradeuterio-1H-benzimidazol-2-yl)-1,3-thiazole
4.2 InChl
InChI=1S/C10H7N3S/c1-2-4-8-7(3-1)12-10(13-8)9-5-14-6-11-9/h1-6H,(H,12,13)/i1D,2D,3D,4D
4.3 InChlKey
WJCNZQLZVWNLKY-RHQRLBAQSA-N
4.4 Canonical SMILES
C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3
4.5 lsomeric SMILES
[2H]C1=C(C(=C2C(=C1[2H])NC(=N2)C3=CSC=N3)[2H])[2H]
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病